Spectrum Plastics Group, an Alpharetta, Ga.-based medical components and contract manufacturer, acquired Earnan Biomedical Ltd, a Wexford, Ireland-based leader in the innovation of medical balloon technologies and solutions.
The amount of the deal was not disclosed.
The acquisition represents additional investment for Spectrum Plastics overseas and in Ireland in particular, contributing to its established manufacturing presence and operation in Tullamore.
Led by Mr. Colin Sutherland, Earnan Biomedical specializes in the design, development, and manufacture of custom balloon forming technologies. Its suite of capabilities includes textured and non-textured balloons across a wide variety of materials, including nylon, polyurethane, and polyester.
Additional developments include multi-layered balloon designs and high-pressure products. Applications range across cardiovascular, gastrointestinal, nutrition, neurovascular, wound care, and orthopedic solutions.
Spectrum Plastics will retain the Earnan name as the brand under which its balloon solutions will be marketed — Earnan™ balloons by Spectrum Plastics Group.
Mr. Sutherland will remain with Spectrum Plastics as Vice President of Balloon Technologies and direct the Wexford, Ireland center of excellence for balloon innovation, which will become part of Spectrum Plastics’ Vascular Technologies division.
Led by Neil Shillingford, CEO, Spectrum Plastics is a North American leader in the design and fabrication of custom and specialty plastics products focusing on niche, high value-added end markets, including medical, food, and defense applications. The company offers a full range of custom design, engineering and fabrication services, as well as meet the requirements of ISO 9001, ISO 13485, and operates multiple Class 7 & Class 8 clean rooms.